Concepedia

Jinglan Pei

JP

Statistics

Publications

21

Citations

1.6K

H-Index

16

Active since

2009

Affiliations

Roche (Switzerland)(Current)

Roche (United Kingdom)

Cleveland Clinic

Stanford University

Multiple Sclerosis Center Of Northeastern New York

Jinglan Pei is an author at Roche (Switzerland) specializing in pharmacotherapy, medicine, and rheumatology.

Publications per year

2009–2023

21

Publications

21

Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes

Pierluigi Tricoci, Zhen Huang, Claes Held et al. · New England Journal of Medicine · 2011 · 753 citations · Full text

Medicine, Cardiology, Pharmacology +16

Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study

Richard C. Becker, David J. Moliterno, Lisa K. Jennings et al. · The Lancet · 2009 · 297 citations

Medicine, Cardiology, Pharmacotherapy +10

Low immunogenicity of tocilizumab in patients with rheumatoid arthritis

Gerd R Burmester, Ernest Choy, Alan Kivitz et al. · Annals of the Rheumatic Diseases · 2016 · 102 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations

Sebastian Unizony, Timothy J. McCulley, Robert Spiera et al. · Arthritis Research & Therapy · 2021 · 60 citations · Full text

Life Sciences, Clinical Sciences, Pharmacotherapy +13

Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial

Edward Fox, Clyde Markowitz, Angela Applebee et al. · Multiple Sclerosis Journal · 2018 · 52 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +15

1–5 of 21